z-logo
open-access-imgOpen Access
USING NANOPARTICLES FOR ENHANCING THE FOCUSING HEATING EFFECT OF AN EXTERNAL WAVEGUIDE APPLICATOR FOR ONCOLOGY HYPERTHERMIA: EVALUATION IN MUSCLE AND TUMOR PHANTOMS
Author(s) -
Citlalli Jessica Trujillo-Romero,
Sonia GarcíaJimeno,
A. Vera,
L. Leija,
Joan Estelrich
Publication year - 2011
Publication title -
electromagnetic waves
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 89
eISSN - 1559-8985
pISSN - 1070-4698
DOI - 10.2528/pier11092911
Subject(s) - hyperthermia , nanoparticle , materials science , hyperthermia therapy , superparamagnetism , biomedical engineering , magnetite nanoparticles , magnetic nanoparticles , waveguide , magnetite , polyethylene glycol , nanotechnology , medicine , optoelectronics , magnetic field , chemistry , physics , magnetization , organic chemistry , quantum mechanics , metallurgy
A technical challenge in hyperthermia therapy is to locally heat the tumor region up to an appropriate temperature to destroy cancerous cells, without damaging the surrounding healthy tissue. Magnetic fluid hyperthermia (MFH) is a novel, minimally invasive therapy aiming at concentrating heat inside cancerous tissues. This therapy is based on the injection of different superparamagnetic nanoparticles inside the tumor. In our study, superparamagnetic nanoparticles, which we developed and characterized, consisted of iron oxide nanoparticles stabilized with polyethylene glycol. Moreover, a new technique for MFH using a specially designed external electromagnetic waveguide as applicator is presented. Three magnetite concentrations were used for making the tumor phantoms, which were embedded in muscle phantoms. The phantoms were radiated and located at three different distances from the applicator. Furthermore, two volumes of tumor (2.5mL and 5.0mL) were assayed. Heating curves, as a function of time, allowed the establishment of a more appropriate nanoparticle concentration for obtaining the temperature increase suitable for hyperthermia therapy. The results shown in this Received 29 September 2011, Accepted 19 October 2011, Scheduled 1 November 2011 * Corresponding author: Citlalli Jessica Trujillo-Romero (ctrujillo@cinvestav.mx). The technical contribution of the second author to this work was as significant as the first

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom